Clinic
Ladd Memorial Hospital
Ladd Memorial Hospital was paid $1.21M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99282, Emergency department visit for the evaluation and management, low to moderate severity — 24% of everything it billed.
33Billing provider infoLADD MEMORIAL HOSPITAL
OSCEOLA, WI 54020
OSCEOLA, WI 54020
33aNPI1467560227assigned 08/29/2006
33bProvider typeCritical Access Hospital Clinic/Center
28Total paid$1.21M
24GClaims46,457
24DCodes billed67
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,444 | $130K | |
| 2019 | 5,663 | $119K | |
| 2020 | 3,477 | $110K | |
| 2021 | 6,505 | $225K | |
| 2022 | 7,151 | $203K | |
| 2023 | 7,605 | $231K | |
| 2024incomplete | 7,612 | $186K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 24% | 1,526 | 1,232 | $290K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 19% | 1,371 | 1,116 | $230K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 1,175 | 921 | $179K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 5.3% | 1,791 | 1,425 | $63K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.1% | 2,582 | 2,263 | $61K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.6% | 672 | 623 | $56K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.7% | 542 | 377 | $45K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.5% | 1,509 | 1,291 | $43K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.7% | 1,639 | 647 | $33K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 4,048 | 2,954 | $22K |
| 80053 | Comprehensive metabolic panel | 1.8% | 2,704 | 2,068 | $22K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.6% | 2,398 | 1,744 | $19K |
55 more codes
| 71046 | Radiologic examination, chest; 2 views | 1.5% | 499 | $18K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.3% | 1,208 | $16K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 1,086 | $16K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 370 | $13K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 910 | $7K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 23 | $7K |
| 85610 | <1% | 929 | $6K | |
| 81003 | <1% | 1,133 | $6K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 22 | $6K |
| 80061 | Lipid panel | <1% | 473 | $5K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 418 | $5K |
| 85027 | <1% | 896 | $4K | |
| 87631 | <1% | 35 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 193 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,057 | $3K |
| 81025 | <1% | 338 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 142 | $3K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 900 | $2K |
| 81001 | <1% | 567 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 316 | $2K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 98 | $2K |
| 82728 | <1% | 145 | $1K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 83 | $1K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 58 | $944.21 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 386 | $896.24 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 43 | $822.67 |
| J3490 | Unclassified drugs | <1% | 1,634 | $775.72 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 606 | $656.19 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 14 | $643.59 |
| 90686 | <1% | 81 | $622.18 | |
| 86140 | <1% | 169 | $554.10 | |
| 83735 | <1% | 146 | $500.69 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 93 | $406.79 |
| 85018 | <1% | 173 | $393.27 | |
| 36416 | <1% | 717 | $320.19 | |
| 80306 | <1% | 18 | $243.70 | |
| 87634 | <1% | 29 | $211.46 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 29 | $202.93 |
| 87210 | <1% | 36 | $154.60 | |
| 83690 | <1% | 35 | $114.33 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13 | $108.60 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 281 | $98.09 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 171 | $91.65 |
| J2704 | Injection, propofol, 10 mg | <1% | 658 | $76.00 |
| 87081 | <1% | 13 | $68.84 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 472 | $12.28 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 340 | $7.83 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 38 | $2.00 |
| 0353U | 0% | 13 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 198 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 56 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 48 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 38 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 23 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMACKEN-MARBLE, KELLY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Ladd Memorial Hospital | Osceola, WI | $464K |
| United Surgeons, LLC | Mishawaka, IN | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.